Lanean...
CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina
BACKGROUND: Categorization as a cytochrome P450 (CYP) 2C19 poor metabolizer (PM) is reported to be an independent risk factor for cardiovascular disease. Epoxyeicosatrienoic acids (EETs) are metabolites of arachidonic acid by CYP2C19 epoxygenases and anti-inflammatory properties, especially in micro...
Gorde:
| Argitaratua izan da: | Int J Cardiol Heart Vasc |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5458130/ https://ncbi.nlm.nih.gov/pubmed/28616567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2017.03.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|